437 related articles for article (PubMed ID: 8247035)
1. Liver transplantation in European patients with the hepatitis B surface antigen.
Samuel D; Muller R; Alexander G; Fassati L; Ducot B; Benhamou JP; Bismuth H
N Engl J Med; 1993 Dec; 329(25):1842-7. PubMed ID: 8247035
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis.
Samuel D; Zignego AL; Reynes M; Feray C; Arulnaden JL; David MF; Gigou M; Bismuth A; Mathieu D; Gentilini P
Hepatology; 1995 Feb; 21(2):333-9. PubMed ID: 7843702
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
[TBL] [Abstract][Full Text] [Related]
4. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
5. Fulminant hepatitis B virus: recurrence after liver transplantation in two patients also infected with hepatitis delta virus.
Marsman WA; Wiesner RH; Batts KP; Poterucha JJ; Porayko MK; Niesters HG; Zondervan PE; Krom RA
Hepatology; 1997 Feb; 25(2):434-8. PubMed ID: 9021960
[TBL] [Abstract][Full Text] [Related]
6. Should liver transplantation be performed for patients with hepatitis B?
Eason JD; Freeman RB; Rohrer RJ; Lewis WD; Jenkins R; Dienstag J; Cosimi AB
Transplantation; 1994 Jun; 57(11):1588-93. PubMed ID: 8009592
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin.
Terrault NA; Zhou S; Combs C; Hahn JA; Lake JR; Roberts JP; Ascher NL; Wright TL
Hepatology; 1996 Dec; 24(6):1327-33. PubMed ID: 8938155
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation for viral hepatitis: the experience of the hepatobiliary center at Hospital Paul Brousse.
Samuel D; Feray C; Bismuth H
Clin Transpl; 1994; ():157-62. PubMed ID: 7547534
[TBL] [Abstract][Full Text] [Related]
9. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis of recurrent hepatitis B in Chinese patients after liver transplantation using lamivudine combined with hepatitis B immune globulin according to the titer of antibody to hepatitis B surface antigen.
Jiao ZY; Jiao Z
Transplant Proc; 2007 Jun; 39(5):1533-6. PubMed ID: 17580182
[TBL] [Abstract][Full Text] [Related]
11. Costs and efficacy of "on demand" low-dose immunoprophylaxis in HBV transplanted patients: experience in the Romanian program of liver transplantation.
Iacob S; Hrehoret D; Matei E; Dorobantu B; Gangone E; Gheorghe L; Popescu I
J Gastrointestin Liver Dis; 2008 Dec; 17(4):383-8. PubMed ID: 19104697
[TBL] [Abstract][Full Text] [Related]
12. Retransplantation of the liver for recurrent hepatitis B virus infection: the Paul Brousse experience.
Roche B; Samuel D; Feray C; Majno P; Gigou M; Reynes M; Bismuth H
Liver Transpl Surg; 1999 May; 5(3):166-74. PubMed ID: 10226106
[TBL] [Abstract][Full Text] [Related]
13. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients.
Huo TI; Yang WC; Wu JC; King KL; Loong CC; Lin CY; Lui WY; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):93-100. PubMed ID: 10677918
[TBL] [Abstract][Full Text] [Related]
14. Long-term passive immunoprophylaxis of B virus recurrence after liver transplantation in HBs antigen-positive patients.
Gugenheim J; Crafa F; Fabiani P; Goubaux B; Ouzan D; Mouiel J
Transplant Proc; 1993 Feb; 25(1 Pt 2):1349-50. PubMed ID: 8442140
[No Abstract] [Full Text] [Related]
15. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
[TBL] [Abstract][Full Text] [Related]
16. Long-term prevention of recurrent hepatitis B virus after liver transplantation.
Ilan Y; Eid A; Tur-Kaspa R
Isr J Med Sci; 1995 Aug; 31(8):469-73. PubMed ID: 7635695
[TBL] [Abstract][Full Text] [Related]
17. [Experiences with liver transplantation in hepatitis B antigen positive liver cirrhosis].
Steininger R; Mühlbacher F; Längle F; Gnant M; Sautner T; Götzinger P; Walgram M; Penner E; Radaszkiewicz T
Wien Klin Wochenschr; 1991; 103(19):573-6. PubMed ID: 1759457
[TBL] [Abstract][Full Text] [Related]
18. [Recurrence of virus B hepatitis after liver transplantation].
Gugenheim J; Crafa F; Fabiani P; Militerno G; Goubaux B; Saint-Paul MC; Ouzan D; Mouiel J
Gastroenterol Clin Biol; 1992; 16(5):430-3. PubMed ID: 1326456
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus infection in allogeneic bone marrow transplantation.
Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation and HBsAg-positive postnecrotic cirrhosis: adequate immunoprophylaxis and delta virus co-infection as the significant determinants of long-term prognosis.
Lerut JP; Donataccio M; Ciccarelli O; Roggen F; Jamart J; Laterre PF; Cornu C; Mazza D; Hanique G; Rahier J; Geubel AP; Otte JB
J Hepatol; 1999 Apr; 30(4):706-14. PubMed ID: 10207814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
